We can’t show the full text here under this license.
How New Obesity Drugs May Affect Weight Stigma and Public Attitudes
Updated
Abstract
have shown effectiveness in reducing weight and improving health outcomes for individuals with obesity.
- The use of GLP-1 receptor agonists may help reframe obesity as a medical issue rather than a personal failure.
- Disparities in access and high costs of these medications could exacerbate existing biases against individuals who cannot afford treatment.
- Some users may experience stigma for using medications perceived as an 'easy way out' to lose weight.
- Legal actions and equitable access to these medications are essential for mitigating stigma.
- Supportive healthcare and educational campaigns could reshape negative perceptions of obesity as a complex health issue.
Simplified
Key numbers
15–20%
Average Weight Loss
Weight loss achieved with .
40–50%
40–50%
Prevalence of among people living with obesity.